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Abstract: 
 Scales from adult zebrafish, Danio rerio, are an established model for studying osteoblast 
and osteoclast activity. In this study, scales in a cell culture were used to determine if the 
hormone leptin has an effect on activity of these bone remodeling scales. Alkaline phosphatase 
(ALP) and tartrate-resistant acid phosphatase (TRAP) activities of zebrafish scales were 
measured and compared with and without leptin treatment. There was no statistically significant 
difference between leptin treatments in terms of ALP and TRAP activity. Differences between 
TRAP values between days 1 and 2 did look promising although they were not statistically 
significant. This study could provide an insight into any effect that leptin may have on bone 
metabolism considering the differences in TRAP activity as previously mentioned. A viable 
scale assay model, however, was established which can contribute to the understanding of the 
molecular role of leptin in bone metabolism.  
Introduction: 
 Seen as a “master hormone” (Takeda, et al. 2002), leptin regulates appetite and metabolic 
rate, as well as reproduction, immune function, and bone growth/resorption (Londraville, et al. 
2017). Bone growth and resorption are of interest in terms of how to treat osteodegenerative 
diseases (e.g., osteoporosis), and leptin is of research interest due to its antiosteogenic and 
anorexigenic effects that act independently of each other. Antiosteogenic and anorexigenic 
effects are associated with the sympathetic and central nervous systems, respectively (Takeda, et 
al. 2002; Philbrick, et al. 2017). Because it must cross the blood-brain barrier, leptin has limited 
entry into the central nervous system (Philbrick, et al. 2017). Normal bone growth in mice 
requires leptin, and without signaling, skeletal abnormalities - including decreased bone length 
and total bone-mass can occur. These abnormalities can be reversed by administering the 
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hormone, but too much administered directly into the hypothalamus can activate leptin’s 
antiosteogenic effects (Philbrick, et al. 2017). Leptin does not affect the total number of 
osteoclasts, but rather their activity (Philbrick, et al. 2017; Pasqualetti, et al. 2012). 
 In mammals, leptin is synthesized by adipose tissue and travels to the hypothalamus 
across the blood-brain barrier where it binds to the leptin receptor and regulates appetite and 
lipid mobilization for metabolism; in bony fish, such as zebrafish, it is primarily expressed in the 
liver (Londraville, et al. 2017). Zebrafish express both LEPA and B as well as their subtypes. 
They are effective models when studying the possible effects of leptin on humans since there is 
some evolutionary conservation of tertiary protein structures after bony fish diverged from 
humans. Leptin binds to its receptor in a zebrafish hypothalamus in a similar fashion to a 
human’s due to the conservation of the protein folding (Londraville, et al. 2017).  
 Zebrafish scales, like human bone, have osteoblasts and osteoclasts (bone-forming and 
resorptive cells, respectively), making zebrafish scales ideal when studying leptin’s effects on 
osteogenesis. Osteoblasts have been known to play a role in bone-formation as well as regulating 
osteoclast maturation, which then perform bone resorption (Tanaka, et al. 2005). They also have 
all organs for metabolic activity present in humans (Carnovali, et al. 2018). Zebrafish elasmoid 
scales form internal circuli when the scales are forming new collagen fibers into the bone matrix, 
as can be visualized using staining techniques (Pasqualetti, et al. 2012 A). Osteoblasts are 
present on both the episquamal and hyposquamal surfacess of the scale. On the episquamal 
surface, they deposit a mineralized tissue layer organized in circuli, while the hyposquamal side 
deposits collagen that makes up the basal plate of the scale (Pasqualetti, et al. 2012 A). The 
episquamal has two areas, the central and lateral areas, where the osteoblasts are arranged 
differently. Osteoblasts in the central area are distributed randomly and organized in cords where 
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ring mineralization is more consistent. In the lateral area, osteoblasts are organized in a well-
defined pattern along the circuli, and more circuli form in a cranial-caudal pattern, adding to the 
scale surface of the zebrafish (Pasqualetti, et al. 2012 A). 
 There also seems to be a connection between obesity and bone health as shown by 
Carnovali, et al. (2018). They found that in zebrafish fed a high-fat diet, there was decreased 
alkaline phosphatase (ALP) activity and increased tartrate-resistant acid phosphatase (TRAP) 
activity. ALP is characteristic of osteoblast (bone cell formation) activity and thus can be used to 
quantitatively measure the osteoblastic activity. TRAP assays indicate osteoclast (bone cell 
resorption) activity and is used as a quantitative measure for osteoclast activity. Carnovali, et al. 
(2018) found that increased leptin along with a decrease in adiponectin secretion were associated 
with bone resorption in obese fish, explaining the increased TRAP activity. With its similarities 
in bone metabolism to humans, zebrafish can be used to understand if leptin is related to bone 
metabolism and spur future research into the hormone’s role in bone diseases such as 
osteoporosis. Thus, our main objective is to determine if leptin has a significant effect on bone 
metabolism in terms of ALP and TRAP activity. We believe that leptin may have some effect on 
osteoclast activity after evidence seen in mice, where normal bone growth requires leptin 
(Philbrick, et al. 2017). 
Methods and Materials 
Animals 
 Adult zebrafish of AB stock (ZIRC) from the Londraville lab colony were used. 
Zebrafish used for scale removal were anesthetized by being placed in 0.01% MS222 until they 
lost equilibrium. Total wet weight (0.351 g ± 0.106) and length (34.6 mm ± 2.52) of each fish (n 
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= 5) were measured. Scale removal was performed under a dissecting microscope using a wetted 
stage and watchmaker forceps to remove scales from just behind the operculum. No more than 3 
scales from each side of the fish were removed at a time. Removed scales were placed in 
phosphate-buffered saline (PBS) before being placed in cell culture medium for incubation. 
 
 
 
 
 
Figure 1: D. rerio (zebrafish). White arrow shows location of the operculum. Red arrow shows 
the area where a scale was extracted from each side of the fish. (source: 
https://www.britannica.com/animal/zebra-danio) 
Culture Medium Preparation 
Culture medium was prepared to determine if it was possible to keep an isolated zebrafish 
scale alive and growing over a 48-hour period. Culture medium was prepared using L-15 
Leibovitz Medium with a pH indicator, Phosphate Buffer Saline (PBS), Penicillin-Streptomycin 
mixture, and Fetal Bovine Serum as described by Pasqualetti, et al., (2012). Preparation of the 
mixture was performed in a sterile cell culture hood. 500 mL total of culture medium was made 
using 450 mL L-15, 50 mL PBS, and 2% of antibiotics relative to the total volume of medium. 
Since the Penicillin-Streptomycin mixture was at 100x concentration, 5 mL was added to the 
solution. From a 500 mL bottle of L-15, 55 mL was removed and discarded. 50 mL of PBS was 
added to the remaining L-15, then 5 mL of antibiotic mixture, and the entire solution was mixed. 
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The medium was supplemented with 10% fetal bovine serum. Aliquots of 5 mL were placed in 
sterile 7 mL vials and refrigerated.  
Incubation and Assay Troubleshoot 
Initial trials were contaminated by bacterial growth as was indicated by a color change of 
the culture medium from pink to yellow. Sterilization of scales was subsequently performed after 
removal to reduce contamination. The scales were removed from the fish, immersed in 70% 
ethanol for 5 seconds, then placed in PBS for transportation to the cell culture hood for 
placement into medium. Originally, wells were used for incubation, but showed signs of leakage 
into neighboring wells. Thereafter, individual 200 μL centrifuge tubes were instead used for 
individual scale incubation. Scales were originally homogenized using a Sonicator, and 
thereafter with a Bullet Blender (West Advance, Troy, NY) using 1.0 mm zirconium oxide 
beads. 
Incubation 
 Scales (n=6) freshly removed from the fish (no culture) were assayed for ALP and TRAP 
activity for comparison to scales in culture. Remaining scales (n=12) were placed in centrifuge 
tubes with 100 μL of culture medium. Scales were incubated in individual centrifuge tubes in a 
shaking incubator at 28℃ for 48 hours. After 24 hours, 6 scales were removed from incubation 
and assayed for ALP and TRAP activity. The remaining 6 scales received new media and were 
tested under the assays after another 24 hours, for 48 hours total incubation. 
Performance of Assays and Proper Incubation 
 To remove the incubated scales from the centrifuge tubes, they were centrifuged for 45 
seconds at 1,000 rpm and the medium was removed using a micropipette. The ALP assay was 
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performed as described by Persson, et al. (1995) and the TRAP assay was performed as 
described by Suzuki, et al. (2009). Modifications were made to the ALP assay as follows: the 
scales were homogenized, 180 μL of buffer and 0.674 M of pNPP, and no stop solution was 
added after the 2-hour incubation time.  Modifications made to the TRAP assay were as follows: 
180 μL of buffer and 0.674 M of pNPP were used. Scales that were tested for Day 0 ALP and 
TRAP results were immediately placed in assay buffers after sterilization. Once in assay buffers, 
the scales were homogenized in the bead beater twice at 5-minute intervals, for a total of 10-
minute homogenization, then incubated in a digital incubator for 2 hours at 28℃. Controls 
received the same incubation treatment. Samples were then placed in a microplate reader wells 
and read using a at 405 nm. The process was repeated for samples incubated after 24 and 48 
hours. ALP and TRAP net activity was processed through a one-way ANOVA test using 
Microsoft Excel. 
 On Day 0 of trials, no leptin was added to any samples, and 6 scales were tested to 
determine a baseline. On days 1 (24 hours) and 2 (48 hours), 0.5 μM recombinant zebrafish 
leptin A (Genscript) was added to 12 scales and 12 scales received no leptin. Fresh 15 μM 
aliquots of leptin was added to the day 2 scales when media was changed daily. These aliquots 
were pre-prepared and frozen when not in use. 
Table 1: Treatments on scales per day and assay. X lep = no leptin treatment; lep = leptin 
treatment. 
Day: Day 0   
Day 1 
(24 hs)       
Day 2 
(48 hs)       
Assay: ALP TRAP ALP   TRAP   ALP   TRAP   
Treatment
: X lep X lep X lep lep X lep lep X lep lep X lep lep 
# scales: 3 3 3 3 3 3 3 3 3 3 
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Results: 
 All fish were measured for length and weight and their mean and standard deviations 
calculated. The mean length was 34.56 mm ± 2.52 mm and the mean weight was 0.351 g ± 0.106 
g (n = 18 fish). Table 2 shows the net background activity for all treatment groups over the 
period of the study. Table 3 provides the lengths and weights of all zebrafish individuals used, as 
well as the mean and standard deviation among the individuals. Net activity of ALP and TRAP 
was calculated using a one-way ANOVA, where net activity was calculated by subtracting the 
control from background activity. The ALP one-way ANOVA found a p-value of 0.729, as seen 
in Table 4, which is not statistically significant. TRAP one-way ANOVA results showed a p-
value of 0.530, as seen in Table 5, which is also not statistically significant. In Fig. 2, outliers of 
ALP values are present. Furthermore, Fig. 2 shows no significant difference among the treatment 
groups. Fig. 3 shows similar results for TRAP activity with no significant difference among the 
treatment groups and outliers present.  
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Table 2: Net ALP and TRAP activity. Net = activity – background. Negative values were due to 
the control value being larger than the background activity. 
  
ALP X 
lep 
ALP 
lep 
TRAP X 
lep 
TRAP 
lep 
9/25/2019 0.279 0.352 0.052 0.011 
  0.587 0.252 0.007 0.023 
  0.55 0.928 0.023 0.025 
9/26/2019 0.197 0.408 0.016 0.014 
  0.128 0.612 0.079 0.005 
  0.008 0.151 0.012 0.034 
10/2/2019 0.426 0.473 0.006 0.007 
  0.538 0.369 0.006 0.012 
  0.653 0.233 0.015 0.01 
10/3/2019 0.343 0.208 0.006 0.011 
  0.259 0.2 0.016 0.022 
  0.176 0.148 0.013 0.014 
10/9/2019 0.489 0.311 0.01 0.06 
  0.361 0.493 0.011 0.009 
  0.55 0.482 0.011 0.01 
10/10/201
9 0.241 0.283 0.035 0.041 
  0.184 0.15 0.019 0.04 
  0.316 0.265 0.032 0.02 
10/16/201
9 0.895 0.628 -0.01 -0.011 
  0.279 0.318 -0.001 0.048 
  1.151 0.65 0.008 0.013 
10/17/201
9 0.652 0.683 0.014 0.037 
  0.499 1.246 0.034 0.029 
  0.776 1.796 0.038 0.024 
10/23/201
9 0.457 0.542 0.076 0.086 
  0.475 0.559 0.068 0.088 
  0.421 0.264 0.072 0.186 
10/24/201
9 0.155 0.224 0.027 0.025 
  0.315 0.171 -0.004 0.004 
  0.325 0.111 0.062 0.01 
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Table 3: Weight (g) and length (mm) of each fish used. Average weight and length were 
calculated as well as the standard deviation 
Day weight (g) length (mm) 
9/24/2019 0.284 32 
  0.222 36 
  0.289 31 
  0.342 35 
  0.195 35 
10/1/2019 0.373 35 
  0.245 33 
  0.347 36 
  0.266 32 
  0.188 29 
10/8/2019 0.582 38 
  0.472 39 
  0.259 33 
  0.242 30 
  0.489 36 
10/15/201
9 0.386 35 
  0.359 34 
  0.383 35 
  0.312 33 
  0.563 38 
10/22/201
9 0.416 39 
  0.409 35 
  0.296 34 
  0.373 35 
  0.482 36 
Average 0.35096 34.56 
SD 0.105707 2.5152336 
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Table 4: ANOVA single factor summary chart for ALP net activity. There is no effect of leptin 
treatment on ALP activity (p = 0.729). 
Groups Count Sum Average Variance   
Column 1 30 12.685 0.422833 0.059098   
Column 2 30 13.51 0.450333 0.128378   
ANOVA       
Source of Variation SS df MS F P-value F crit 
Between Groups 0.011344 1 0.011344 0.121016 0.729195 4.006873 
Within Groups 5.436795 58 0.093738    
       
Total 5.448139 59         
 
 
 
Table 5: ANOVA single factor summary chart for TRAP net activity. There is no effect of leptin 
treatment on TRAP activity (p = 0.530). 
Groups Count Sum Average Variance   
Column 1 30 0.753 0.0251 0.000616   
Column 2 30 0.907 0.030233 0.001367   
ANOVA       
Source of Variation SS df MS F P-value F crit 
Between Groups 0.000395 1 0.000395 0.398634 0.530276 4.006873 
Within Groups 0.05751 58 0.000992    
       
Total 0.057905 59         
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Figure 2: Box and whisker plot of ALP activity. Days 1, 2, and 3 received no leptin treatment. 
Days 2L and 3L received treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Box and whisker plot of TRAP activity. Days 1NL, 2NL, and 3NL received no leptin 
treatment. Days 2L and 3L received treatment. 
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Discussion: 
 Leptin’s role in vertebrate osteogenesis is not fully understood. During this study, effects 
of leptin on osteoblast and osteoclast activity was observed and was found to have no significant 
impact on the activity of these bone cells. While there is a trend for TRAP activity to be higher in 
leptin-treated scales, it is not statistically significant. As such, it can be assumed that leptin does 
not have a significant effect on osteoblasts or osteoclasts based on this study. 
 Multiple issues were found while performing this study. Single scales were to be utilized 
for each value. However, due to the small nature of scales and their tendency to adhere to one 
another, there were instances where some values could have measured two scales instead of one. 
While the scales are visible to the naked eye, at times it was difficult to determine if a scale was 
present in individual centrifuge tubes because the scales’ translucent appearance. At times a 
small amount of pigmentation could be seen on the scale, but not on every specimen. 
Furthermore, not all scales were similar in size, so some scales were smaller than others, possibly 
causing variability in results. Issues also arose when absorbance values of samples were found to 
be less than the control absorbance values. In these cases it was assumed that no scale was 
present in the sample. 
 In terms of scale size, there were difficulties in ensuring that all scales were of similar 
sizes. We found that there were both large and small scales within the sample pool. Attempts 
were made to determine the average weight of a scale but were unsuccessful due to the size of 
the scales. A large number of scales at one time (dozens) was needed to register at all on our 
most sensitive scale. Removing such a large amount of scales can be unsafe for the fish, so it is 
inappropriate to remove so many to find an average scale weight. Leptin was also to be added 
every day to the appropriate tubes at the same time, but this did not occur. At times leptin was 
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not added until a few hours before activity was to be measured. This added variability to leptin 
incubation times. Lastly, there were some instances where the homogenized scales were 
incubated for 2 hours at temperatures greater than 28℃. Enzyme activity could have been 
affected by this change in temperature. 
 Carnovali, et al. (2018) performed a zebrafish scale assay to understand how a high-fat 
diet affects bone metabolism. They found that scales of fish on the high-fat diet had increased 
leptin and showed increased TRAP activity and decreased ALP activity on their scales, causing 
an “osteoporosis-like phenotype” (Carnovali, et al. 2018). These results are consistent with the 
increased (but not significant) TRAP activity seen in this study. The research done by Carnovali, 
et al. (2018) shows that leptin does have an effect on bone metabolism when a high-fat diet is 
taken into consideration. High fat diet changes many variables at once, and another factor may 
be what is affecting scale dynamics (such as insulin). My data provides insight to the possibility 
of leptin alone driving the effect of diet on scale growth. 
 Another study by Frøiland, et al. (2012) studied Arctic charr to determine if leptin plays a 
role in adiposity. Their treatment groups included Arctic charr that were fed in excess from 
March to November and that were food-deprived from March to June, then fed in excess again 
from July to November. They found that leptin increased during the winter months (normal 
fasting time) while the fish lost body fat and were anorexic. Since leptin activity decreased, it 
may also have an effect on scale growth and bone metabolism. Our scale assay can provide 
insight into how bone structure could change in Arctic charr during this fasting time. Carnovali 
et al. (2018) has already demonstrated an effect of leptin on bone metabolism with a high fat 
diet, and our scale assay could be implemented into studies like Frøiland, et al. (2018) to 
understand any of leptin’s effects on bone metabolism during fasting. 
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 More research should be performed to determine if leptin truly does influence osteogenic 
pathways. Some values for TRAP had looked promising due to there being a difference in 
absorbance values between days 2 and 3 when leptin was added. If variability could be 
decreased, such as by microscopically calculating the area of each scale and expressing activity 
per unit area, it is possible that an effect could have been seen. This could be performed by 
microscopically taking a photograph of the scales and digitally scaling the sample. As previously 
stated, the weight of a single scale is difficult to measure due to its small size, and multiple scales 
would be required to find an average weight of a single scale. Removal of multiple scales from 
one zebrafish can cause injury to the individual. Thus, area of the scale is a more feasible 
measurement than weight. By determining the amount of activity per unit area, a more precise 
way of determining if leptin has a significant effect can be developed. 
 Leptin regulates many pathways including reproduction, immune function, and bone 
growth/resorption (Londraville, et al. 2017). Studies into how it affects osteogenesis can be 
continued and possibly used in understanding bone diseases such as osteoporosis. It is known 
that leptin does play a significant role in proper bone formation in mice, as shown by Philbrick, 
et al. (2017). However, whether it plays a significant role for zebrafish is still to be determined: 
very few studies exist researching the effects of leptin on bone metabolism in D. rerio, so this 
study has contributed to a hopefully growing area of research. If leptin truly does have a 
significant effect on bone cells, the master hormone can then be used in studies of how to treat 
bone degenerative diseases using zebrafish scales as a model. 
Conclusion: 
 This research was performed to determine if leptin has a significant effect on osteoclasts 
and osteoblasts in a zebrafish scale assay model. ALP and TRAP activities were used as signals 
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for osteoblast and osteoclast activity, respectively. Scales that received leptin treatment showed 
no significant difference in ALP or TRAP activity as compared to scales that received no 
treatment. It is possible that with better control of individual activity, such as amount of activity 
per unit area of scale, a significant difference could be observed. We hope to have future studies 
that include trying to determine amount of activity per unit area to investigate more into leptin’s 
effects on bone metabolism. However, this work established that the zebrafish scale assay model 
is a viable model to investigate leptin’s effects on bone metabolism in fish.  
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